Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Novavax And The NIH Agree To Evaluate A Virus-like Particle (VLP) Vaccine Candidate Against The Novel Influenza A (H1N1) Virus
Novavax, Inc. (Nasdaq: NVAX) and the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) have signed an agreement to cooperate in the evaluation of a virus-like particle (VLP) vaccine candidate against the novel influenza A (H1N1) virus. Novavax has produced influenza A (H1N1) VLP vaccine against the strain recommended by the Centers for Disease Control and Prevention (CDC).

Obama Team Ready To Start Health Reform Rally
The White House launches a media blitz this week to coincide with the shrinking timeline for getting a health reform package passed in the Senate, Roll Call reports.
News of the day
Warning On Athletes' Use Of Prescription Drugs
Athletes could be putting their lives at risk by doping themselves with powerful prescription drugs, a leading academic has warned.
Sexual Health

Excellence In Oncology Awards 2009 Now Open For Entry

The Excellence in Oncology Awards (EinO) 2009 are now open for entry. The Awards, now in their fourth year, recognise and reward best practice in oncology management, education and patient care throughout the UK. Winners will be announced at a prestigious dinner on 6 October 2009 during the National Cancer Research Institute (NCRI) Cancer Conference. "The work undertaken by teams and individuals involved in cancer care across the UK is nothing short of inspiring and it"s terrific to be in a position to reward those who are leading the way," commented Mr Richard Sainsbury, President of the British Oncological Association, Consultant Breast Surgeon at Southampton University Hospitals NHS Trust and Chairman of the Excellence in Oncology Awards 2009 judging panel. "We like to think the benefit of winning an Award extends beyond the prize alone, giving winners" projects additional profile and potential resourcing, which will be strong inducement to enter." No matter how large or small, all projects that have made a difference in cancer management and patient care will be considered. By championing best practice in the treatment and care of cancer patients, the Awards enable teams and individuals to promote the valuable work they do both internally and externally. The award categories and prizes are: - Best Patient Support Initiative in Oncology (÷£1,500 research grant) - Best Professional Education Initiative in Oncology (registration, flights and accommodation for European Oncology related meeting of choice) - Oncology Team of the Year (÷£1,500 grant) - Excellence in Oncology Nursing (÷£1,500 grant) - Best Charitable Initiative (engraved silver rose bowl) - BOA Young Investigator Award (÷£500 research grant) - Excellence in Cancer Reporting (÷£500) - Pfizer Lifetime Achievement (÷£2,500) The awards are judged by a panel of eminent leaders in the oncology arena and supported by Pfizer Limited and the British Oncological Association. Who can enter? - All oncology healthcare professionals (surgeons, oncologists, nurses, GPs, pharmacists, dieticians, radiologists, haematologists, psychologists, and other allied health professionals such as physiotherapists and occupational therapists) - Patient and professional associations as well as charities. The deadline for entries is 5.00pm on Friday, 31 July 2009. More information and an entry form are available on the website: http://www.excellenceinoncology.org. Excellence in Oncology Awards


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009